| UBS MSCI CANADA UCITS ETF HGBP ACC | RVI USA | 33,49% | 80,16% | 92,69% | · |
| WELLINGTON EMERGING MARKETS RESEARCH EQUITY CORE FUND S GBP ACC | RVI EMERGENTES | 33,48% | 43,74% | 12,63% | · |
| DWS INVEST CRITICAL TECHNOLOGIES LD | TMT | 33,47% | 53,75% | 51,26% | · |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 33,47% | 5,94% | -36,15% | · |
| ABRDN SICAV I-EMERGING MARKETS EQUITY FUND A ACC USD | RVI EMERGENTES | 33,46% | 33,25% | 1,29% | 64,57% |
| BGF WORLD ENERGY C2 USD | ENERGÍA | 33,46% | 38,14% | 143,15% | 105,31% |
| GOLDMAN SACHS GLOBAL FUTURE TECHNOLOGY LEADERS EQUITY PORTFOLIO E EUR CAP | TMT | 33,46% | 53,92% | 9,14% | · |
| UBS CMCI EX-AGRICULTURE SF UCITS ETF HCHF ACC | MATERIAS PRIMAS | 33,46% | · | · | · |
| UBS (LUX) EQUITY SICAV - GLOBAL EMERGING MARKETS OPPORTUNITY (USD) Q-DIST | RVI EMERGENTES | 33,46% | 41,84% | -1,33% | · |
| BNP PARIBAS FLEXI I COMMODITIES IH EUR CAP | MATERIAS PRIMAS | 33,45% | 42,67% | 116,08% | · |
| CT (LUX) ENHANCED COMMODITIES ZFH CHF | MATERIAS PRIMAS | 33,44% | 39,39% | 96,02% | 89,00% |
| SANTANDER INDICE ESPAÑA, FI I | RV ESPAÑA | 33,44% | 106,71% | 135,33% | 181,51% |
| INVESCO NIPPON SMALL/MID CAP EQUITY Z CAP JPY | RVI JAPÓN SMALL/MID CAP | 33,43% | 31,42% | 4,14% | 83,20% |
| MAN JAPAN COREALPHA EQUITY I GBP | RVI JAPÓN | 33,43% | 67,00% | · | 182,76% |
| GENERALI INVESTMENTS SICAV - CENTRAL & EASTERN EUROPEAN EQUITY DX | RVI EMERGENTES EUROPA | 33,42% | 115,30% | 135,03% | 119,42% |
| JPM ASIA PACIFIC EQUITY I (ACC) EUR | RVI ASIA EX-JAPÓN | 33,42% | 51,09% | 27,24% | · |
| AB SICAV I-GLOBAL VALUE PORTFOLIO S GBP H | RVI GLOBAL VALOR | 33,41% | 68,68% | 54,67% | 108,49% |
| INVESCO NIPPON SMALL/MID CAP EQUITY C DIS ANNUAL USD | RVI JAPÓN SMALL/MID CAP | 33,41% | 30,39% | 2,70% | 78,75% |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) EUR (HEDGED) | BIOTECNOLOGÍA | 33,41% | 5,72% | -36,43% | · |
| UBS MSCI EM SOCIALLY RESPONSIBLE UCITS ETF USD ACC | RVI EMERGENTES | 33,41% | 52,49% | 29,51% | · |
